GALR2
Galanin receptor type 2
Also known as: GALNR2, GALR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43603
- Gene
- GALR2
- Ensembl
- ENSG00000182687
- Chromosome
- 17
- Canonical length
- 387 aa
- Protein class
- G-protein coupled receptors, Plasma proteins, Predicted membrane proteins
OverviewNCBI Gene
Galanin is an important neuromodulator present in the brain, gastrointestinal system, and hypothalamopituitary axis. It is a 30-amino acid non-C-terminally amidated peptide that potently stimulates growth hormone secretion, inhibits cardiac vagal slowing of heart rate, abolishes sinus arrhythmia, and inhibits postprandial gastrointestinal motility. The actions of galanin are mediated through interaction with specific membrane receptors that are members of the 7-transmembrane family of G protein-coupled receptors. GALR2 interacts with the N-terminal residues of the galanin peptide. The primary signaling mechanism for GALR2 is through the phospholipase C/protein kinase C pathway (via Gq), in contrast to GALR1, which communicates its intracellular signal by inhibition of adenylyl cyclase through Gi. However, it has been demonstrated that GALR2 couples efficiently to both the Gq and Gi proteins to simultaneously activate 2 independent signal transduction pathways. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
387 residues, UniProt reviewed canonical sequence.
>O43603|GALR2
1 MNVSGCPGAG NASQAGGGGG WHPEAVIVPL LFALIFLVGT VGNTLVLAVL LRGGQAVSTT
61 NLFILNLGVA DLCFILCCVP FQATIYTLDG WVFGSLLCKA VHFLIFLTMH ASSFTLAAVS
121 LDRYLAIRYP LHSRELRTPR NALAAIGLIW GLSLLFSGPY LSYYRQSQLA NLTVCHPAWS
181 APRRRAMDIC TFVFSYLLPV LVLGLTYART LRYLWRAVDP VAAGSGARRA KRKVTRMILI
241 VAALFCLCWM PHHALILCVW FGQFPLTRAT YALRILSHLV SYANSCVNPI VYALVSKHFR
301 KGFRTICAGL LGRAPGRASG RVCAAARGTH SGSVLERESS DLLHMSEAAG ALRPCPGASQ
361 PCILEPCPGP SWQGPKAGDS ILTVDVALocalizationUniProt · AlphaFold · HPA
Whether an antibody against GALR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 7.3 nTPM
Expression across tissuesHPA
Tissue
- colon: 7.3 nTPM
- small intestine: 5.6 nTPM
- smooth muscle: 1.6 nTPM
- bone marrow: 0.8 nTPM
- esophagus: 0.8 nTPM
- hypothalamus: 0.5 nTPM
Single-cell type
- cdc: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
Immune cell
- neutrophil: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- intermediate monocyte: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- hypothalamus: 1.6 nTPM
- medulla oblongata: 1.6 nTPM
- pons: 1.5 nTPM
- spinal cord: 1.3 nTPM
- basal ganglia: 1.1 nTPM
- cerebral cortex: 1.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.69
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.39
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- adenylate cyclase-modulating G protein-coupled receptor signaling pathway
- feeding behavior
- galanin-activated signaling pathway
- inositol phosphate metabolic process
- learning or memory
- muscle contraction
- neuron projection development
- phosphatidylinositol metabolic process
- phospholipase C-activating G protein-coupled receptor signaling pathway
- positive regulation of cytosolic calcium ion concentration
- positive regulation of transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GALR2 as an antibody target. Whether an autoantibody or antibody against GALR2 could matter depends on whether native GALR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GALR2 is annotated at the cell surface, where native GALR2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GALR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...